Mirjana Josipovic1,2, Marianne C Aznar1,2,3,4, Jakob B Thomsen1, Jonas Scherman1,2,5, Sidsel Ms Damkjaer5, Lotte Nygård1, Lena Specht1,4, Mette Pøhl1, Gitte F Persson1,4,6. 1. Department of Oncology, Section of Radiotherapy, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark. 2. Niels Bohr Institute, Faculty of Science, University of Copenhagen, Blegdamsvej 17, 2100 Copenhagen, Denmark. 3. Manchester Cancer Research Centre, Division of Cancer Science, University of Manchester, c/o the Christie NHS, Wilmslow Road, Manchester M20 4BX, UK. 4. Department of Clinical Medicine, Faculty of Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2100 Copenhagen, Denmark. 5. Department of Hematology and Oncology Radiation Physics, Skåne University Hospital, 21185 Lund, Sweden. 6. Department of Oncology, Herlev-Gentofte Hospital, University of Copenhagen, Herlev Ringvej 75, 2730 Herlev, Denmark.
Abstract
OBJECTIVES: Patients with locally advanced non-small cell lung cancer (NSCLC) were included in a prospective trial for radiotherapy in deep inspiration breath hold (DIBH). We evaluated DIBH compliance and target position reproducibility. METHODS: Voluntary, visually guided DIBHs were performed with optical tracking. Patients underwent three consecutive DIBH CT scans for radiotherapy planning. We evaluated the intrafractional uncertainties in the position of the peripheral tumour, lymph nodes and differential motion between them, enabling PTV margins calculation. Patients who underwent all DIBH imaging and had tumour position reproducibility <8 mm were up-front DIBH compliant. Patients who performed DIBHs throughout the treatment course were overall DIBH compliant. Clinical parameters and DIBH-related uncertainties were validated against our earlier pilot study. RESULTS: 69 of 88 included patients received definitive radiotherapy. 60/69 patients (87%) were up-front DIBH compliant. DIBH plan was not superior in seven patients and three lost DIBH ability during the treatment, leaving 50/69 patients (72%) overall DIBH compliant.The systematic and random errors between consecutive DIBHs were small but differed from the pilot study findings. This led to slightly different PTV margins between the two studies. CONCLUSIONS: DIBH compliance and reproducibility was high. Still, this validation study highlighted the necessity of designing PTV margins in larger, representative patient cohorts. ADVANCES IN KNOWLEDGE: We demonstrated high DIBH compliance in locally advanced NSCLC patients. DIBH does not eliminate but mitigates the target position uncertainty, which needs to be accounted for in treatment margins. Margin design should be based on data from larger representative patient groups.
OBJECTIVES: Patients with locally advanced non-small cell lung cancer (NSCLC) were included in a prospective trial for radiotherapy in deep inspiration breath hold (DIBH). We evaluated DIBH compliance and target position reproducibility. METHODS: Voluntary, visually guided DIBHs were performed with optical tracking. Patients underwent three consecutive DIBH CT scans for radiotherapy planning. We evaluated the intrafractional uncertainties in the position of the peripheral tumour, lymph nodes and differential motion between them, enabling PTV margins calculation. Patients who underwent all DIBH imaging and had tumour position reproducibility <8 mm were up-front DIBH compliant. Patients who performed DIBHs throughout the treatment course were overall DIBH compliant. Clinical parameters and DIBH-related uncertainties were validated against our earlier pilot study. RESULTS: 69 of 88 included patients received definitive radiotherapy. 60/69 patients (87%) were up-front DIBH compliant. DIBH plan was not superior in seven patients and three lost DIBH ability during the treatment, leaving 50/69 patients (72%) overall DIBH compliant.The systematic and random errors between consecutive DIBHs were small but differed from the pilot study findings. This led to slightly different PTV margins between the two studies. CONCLUSIONS: DIBH compliance and reproducibility was high. Still, this validation study highlighted the necessity of designing PTV margins in larger, representative patient cohorts. ADVANCES IN KNOWLEDGE: We demonstrated high DIBH compliance in locally advanced NSCLC patients. DIBH does not eliminate but mitigates the target position uncertainty, which needs to be accounted for in treatment margins. Margin design should be based on data from larger representative patient groups.
Authors: Eva E Schaake; Maddalena M G Rossi; Wieneke A Buikhuisen; Jacobus A Burgers; Adrianus A J Smit; José S A Belderbos; Jan-Jakob Sonke Journal: Int J Radiat Oncol Biol Phys Date: 2014-10-18 Impact factor: 7.038
Authors: Gitte F Persson; Jonas Scherman Rydhög; Mirjana Josipovic; Maja V Maraldo; Lotte Nygård; Junia Costa; Anne K Berthelsen; Lena Specht; Marianne C Aznar Journal: Acta Oncol Date: 2016-03-03 Impact factor: 4.089
Authors: Jonas Scherman Rydhög; Steen Riisgaard de Blanck; Mirjana Josipovic; Rasmus Irming Jølck; Klaus Richter Larsen; Paul Clementsen; Thomas Lars Andersen; Per Rugaard Poulsen; Gitte Fredberg Persson; Per Munck Af Rosenschold Journal: Radiother Oncol Date: 2017-02-27 Impact factor: 6.280
Authors: Sidsel M S Damkjær; Marianne C Aznar; Anders N Pedersen; Ivan R Vogelius; Jens Peter Bangsgaard; Mirjana Josipovic Journal: Acta Oncol Date: 2013-08-19 Impact factor: 4.089
Authors: Elisabeth Weiss; Scott P Robertson; Nitai Mukhopadhyay; Geoffrey D Hugo Journal: Int J Radiat Oncol Biol Phys Date: 2011-12-22 Impact factor: 7.038
Authors: Danny Lee; Peter B Greer; Carminia Lapuz; Joanna Ludbrook; Perry Hunter; Jameen Arm; Sean Pollock; Kuldeep Makhija; Ricky T O'Brien; Taeho Kim; Paul Keall Journal: Adv Radiat Oncol Date: 2017-03-10
Authors: Wendy Harris; Ellen Yorke; Henry Li; Christian Czmielewski; Mohit Chawla; Robert P Lee; Alexandra Hotca-Cho; Dominique McKnight; Andreas Rimner; D Michael Lovelock Journal: Med Phys Date: 2022-03-03 Impact factor: 4.071
Authors: Alejandro Prado; Daniel Zucca; Miguel Ángel De la Casa; Jaime Martí; Leyre Alonso; Paz García de Acilu; Juan García; Ovidio Hernando; Pedro Fernández-Letón; Carmen Rubio Journal: Phys Imaging Radiat Oncol Date: 2022-04-29
Authors: Dennis Mah; Ellen Yorke; Entela Zemanaj; Zhiqiang Han; Haoyang Liu; Jobin George; Jason Lambiase; Christian Czmielewski; D Michael Lovelock; Andreas Rimner; Annemarie F Shepherd Journal: Med Dosim Date: 2021-08-21 Impact factor: 1.531
Authors: Evan Liang; Jennifer L Dolan; Eric D Morris; Jonathan Vono; Luisa F Bazan; Mei Lu; Carri K Glide-Hurst Journal: Adv Radiat Oncol Date: 2022-01-04
Authors: Jaehyeon Park; Ji Woon Yea; Se An Oh; Jongmoo Park; Jae Won Park; Jeong Eun Lee Journal: Cancers (Basel) Date: 2022-09-02 Impact factor: 6.575